Topical cidofovir in monkeypox: our experience. Comment on 'Monkeypox: is topical cidofovir a good idea'
Clin Exp Dermatol
.
2023 Jun 5;48(6):700-701.
doi: 10.1093/ced/llad077.
Authors
Tristán Gabriel Sobral-Costas
1
,
Rafael Escudero-Tornero
1
,
Guillermo Servera-Negre
1
,
Jose I Bernardino
2
,
Almudena Guitiérrez Arroyo
3
,
Marta Díaz-Menéndez
4
,
Jose Manuel Busto-Leis
1
,
Patricia Roces Álvarez
2
,
Pedro Herranz Pinto
1
,
Elena Sendagorta Cudós
1
Affiliations
1
Dermatology Department.
2
HIV and Infectious Diseases Unit.
3
Microbiology Department.
4
National Referral Centre for Tropical Diseases and International Health, La Paz University Hospital, Madrid, Spain.
PMID:
36840640
DOI:
10.1093/ced/llad077
No abstract available
Publication types
Comment
MeSH terms
Administration, Topical
Antiviral Agents / therapeutic use
Cidofovir / therapeutic use
Humans
Mpox (monkeypox)* / drug therapy
Substances
Cidofovir
Antiviral Agents